-
公开(公告)号:EP2519538A1
公开(公告)日:2012-11-07
申请号:EP10799265.3
申请日:2010-12-30
申请人: Scynexis, Inc.
摘要: The invention relates to the use of cyclic compounds of general formula (I): wherein A, B, R
1 and R
2 are as defined in the specification, and their use as pharmaceuticals, e.g. in the treatment of HCV infections. In particular, • R
1 is selected from hydrogen, alkyl, alkenyl, XR
3 ; • R
2 is selected from alkyl, alenyl, alkynyl, cycloalkyl, all of which can be optionally substituted; • R
3 is selected from the same moieties of R
2 , plus alkoxycarbonyl. The preferred compounds are cyclosporine analogues carrying an ether functionality on the side chain of Leu-4.